Continual correlation noted between LRRK2 mutations and pain emergence, though conflicting research outcomes pose challenges in reaching definitive conclusions.

Genetic_Association Score: 0.500 Price: $0.50 Parkinson's disease human Status: extracted

What This Experiment Tests

Genetic_Association experiment designed to assess clinical efficacy targeting LRRK2 in human. Primary outcome: Continual correlation noted between LRRK2 mutations and pain emergence, though conflicting research

Description

Conflicting evidence across studies included in systematic review

TARGET GENE

LRRK2

MODEL SYSTEM

human

ESTIMATED COST

TIMELINE

0 months

PATHWAY

null

SOURCE

pmid_38020640

PRIMARY OUTCOME

Continual correlation noted between LRRK2 mutations and pain emergence, though conflicting research outcomes pose challenges in reaching definitive conclusions.

Scoring Dimensions

Related Hypotheses (6)

Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate0.749

G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gai0.790

Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathogenesis (H3)0.780

LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Suppression0.666

LRRK2 Kinase Inhibition Reduces α-Synuclein Spread via Lysosomal Enhancement0.620

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.